174 related articles for article (PubMed ID: 18835137)
1. Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data.
Sendzik J; Lode H; Stahlmann R
Int J Antimicrob Agents; 2009 Mar; 33(3):194-200. PubMed ID: 18835137
[TBL] [Abstract][Full Text] [Related]
2. Use of the new quinolones in pediatrics.
Schaad UB
Isr J Med Sci; 1994; 30(5-6):463-8. PubMed ID: 8034505
[TBL] [Abstract][Full Text] [Related]
3. Systemic quinolone antibiotics in children: a review of the use and safety.
Grady RW
Expert Opin Drug Saf; 2005 Jul; 4(4):623-30. PubMed ID: 16011441
[TBL] [Abstract][Full Text] [Related]
4. Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders.
Noel GJ; Bradley JS; Kauffman RE; Duffy CM; Gerbino PG; Arguedas A; Bagchi P; Balis DA; Blumer JL
Pediatr Infect Dis J; 2007 Oct; 26(10):879-91. PubMed ID: 17901792
[TBL] [Abstract][Full Text] [Related]
5. Critical risk/benefit analysis of pefloxacine use in children under 15 years--the problem of arthralgias.
Chevais M; Reinert P; Rondeau MC; Tobelem R; Albengres E; Riant P; Tillement JP
Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):306-9. PubMed ID: 3476471
[TBL] [Abstract][Full Text] [Related]
6. [Rational therapy of salmonella enteritis].
Hof H; Kretschmar M
Leber Magen Darm; 1994 Mar; 24(2):57-8, 61-4. PubMed ID: 8196466
[TBL] [Abstract][Full Text] [Related]
7. [Arthropathies following the administration of pefloxacin to an adolescent with mucoviscidosis].
Kesseler A; Lacassie A; Hugot JP; Talon P; Thomas D; Astier L
Ann Pediatr (Paris); 1989 Apr; 36(4):275-8. PubMed ID: 2742312
[TBL] [Abstract][Full Text] [Related]
8. [Fluoroquinolones in children].
Gendrel D
Med Trop (Mars); 2002; 62(2):185-92. PubMed ID: 12192718
[TBL] [Abstract][Full Text] [Related]
9. Safety profile of quinolone antibiotics in the pediatric population.
Grady R
Pediatr Infect Dis J; 2003 Dec; 22(12):1128-32. PubMed ID: 14688586
[TBL] [Abstract][Full Text] [Related]
10. Short-term and medium-term clinical outcomes of quinolone-resistant Campylobacter infection.
Evans MR; Northey G; Sarvotham TS; Rigby CJ; Hopkins AL; Thomas DR
Clin Infect Dis; 2009 Jun; 48(11):1500-6. PubMed ID: 19400688
[TBL] [Abstract][Full Text] [Related]
11. Quinolone-induced arthropathy in the neonatal mouse. Morphological analysis of articular lesions produced by pipemidic acid and ciprofloxacin.
Linseman DA; Hampton LA; Branstetter DG
Fundam Appl Toxicol; 1995 Nov; 28(1):59-64. PubMed ID: 8566484
[TBL] [Abstract][Full Text] [Related]
12. Quinolone arthropathy in animals versus children.
Burkhardt JE; Walterspiel JN; Schaad UB
Clin Infect Dis; 1997 Nov; 25(5):1196-204. PubMed ID: 9402381
[TBL] [Abstract][Full Text] [Related]
13. Fluoroquinolones in children: poorly defined risk of joint damage.
Prescrire Int; 2004 Oct; 13(73):184-6. PubMed ID: 15499700
[TBL] [Abstract][Full Text] [Related]
14. European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe.
Ferech M; Coenen S; Malhotra-Kumar S; Dvorakova K; Hendrickx E; Suetens C; Goossens H;
J Antimicrob Chemother; 2006 Aug; 58(2):423-7. PubMed ID: 16735418
[TBL] [Abstract][Full Text] [Related]
15. Children as a special population at risk--quinolones as an example for xenobiotics exhibiting skeletal toxicity.
Stahlmann R
Arch Toxicol; 2003 Jan; 77(1):7-11. PubMed ID: 12491034
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.
Cheng CH; Tsai MH; Huang YC; Su LH; Tsau YK; Lin CJ; Chiu CH; Lin TY
Pediatrics; 2008 Dec; 122(6):1212-7. PubMed ID: 19047236
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of quinolone-induced arthropathy: a review of hypotheses.
Maślanka T; Jaroszewski JJ; Chrostowska M
Pol J Vet Sci; 2004; 7(4):323-31. PubMed ID: 15633793
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging in children receiving quinolones: no evidence of quinolone-induced arthropathy. A multicenter survey.
Danisovicová A; Brezina M; Belan S; Kayserová H; Kaiserová E; Hruskovic I; Orosová K; Dluholucký S; Galova K; Mathéova E
Chemotherapy; 1994; 40(3):209-14. PubMed ID: 8205939
[TBL] [Abstract][Full Text] [Related]
19. P-floxacin induced arthropathy.
Biswal N; Mathai B; Bhatia BD
Indian Pediatr; 1993 May; 30(5):718-9. PubMed ID: 8282410
[No Abstract] [Full Text] [Related]
20. Risks associated with the therapeutic use of fluoroquinolones.
Stahlmann R; Lode HM
Expert Opin Drug Saf; 2013 Jul; 12(4):497-505. PubMed ID: 23651367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
